NCT01641341View on ClinicalTrials.gov

Irritable Bowel Syndrome Evaluation and Treatment in Primary Care

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Bifidobacterium infantis

once a day for seven to eight weeks

DRUG

Pancrelipase

Pancrelipase (one capsule prior to meals or snacks)

DRUG

Nitazoxanide

Nitazoxanide (500mg twice a day for 7 days)

DRUG

Placebo

Placebo capsule will not contain active treatment ingredients.

Trial Locations (9)

14502

Raj Kachoria, Macedon

63801

Family Medicine of SE Missouri, Sikeston

Missouri Delta Physician Services, Sikeston

66209

Overland Park Family Health Partners, Leawood

66211

American Academy of Family Physicians-National Research Network, Leawood

70806

Baton Rouge Family Practice, Baton Rouge

75235

Southwest Family Medicine Associates, Dallas

89521

Silver Sage Center for Family Medicine, Reno

90717

Torrance Clinical Research, Lomita

Sponsors

Collaborators (1)

Genova Diagnostics
All Listed Sponsors
collaborator

Genova Diagnostics

INDUSTRY

lead

American Academy of Family Physicians

OTHER

NCT01641341 - Irritable Bowel Syndrome Evaluation and Treatment in Primary Care | Biotech Hunter | Biotech Hunter